Utility of chemoradiotherapy for head and neck cancer with distant metastases at initial presentation

Mioko Matsuo, Toshimitsu Nishijima, Koji Koike

Research output: Contribution to journalArticle

Abstract

Metastatic (M1) disease is the state in which a malignant tumor has generalized and the principal treatment is drug therapy. However, for head and neck cancer with distant metastases at initial presentation, local control is important for maintaining Quality of Life (QOL) . We retrospectively reviewed 11 cases of head and neck cancer with distant metastases at initial presentation at our hospital from January 2014 to June 2016. Initial treatments were classified as follows: no treatment group, drug therapy group, and chemoradiotherapy group. Local control rate and median survival time were 0% and 4 months in the no treatment group, 0% and 10 months in the drug therapy group, and 83% and 20 months in the chemoradiotherapy group. Chemoradiotherapy was useful for long-term control of a locoregional site and for maintenance of QOL. In addition, chemoradiotherapy may be a useful treatment option for M1 disease patients for improving prognosis.

Original languageEnglish
Pages (from-to)488-492
Number of pages5
JournalJapanese Journal of Head and Neck Cancer
Volume43
Issue number4
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Chemoradiotherapy
Head and Neck Neoplasms
Neoplasm Metastasis
Drug Therapy
Quality of Life
Therapeutics
Group Psychotherapy
Survival Rate
Maintenance
Neoplasms

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Oncology

Cite this

Utility of chemoradiotherapy for head and neck cancer with distant metastases at initial presentation. / Matsuo, Mioko; Nishijima, Toshimitsu; Koike, Koji.

In: Japanese Journal of Head and Neck Cancer, Vol. 43, No. 4, 01.01.2017, p. 488-492.

Research output: Contribution to journalArticle

@article{c5cc49ac0dc74c6582bbfca49bd941da,
title = "Utility of chemoradiotherapy for head and neck cancer with distant metastases at initial presentation",
abstract = "Metastatic (M1) disease is the state in which a malignant tumor has generalized and the principal treatment is drug therapy. However, for head and neck cancer with distant metastases at initial presentation, local control is important for maintaining Quality of Life (QOL) . We retrospectively reviewed 11 cases of head and neck cancer with distant metastases at initial presentation at our hospital from January 2014 to June 2016. Initial treatments were classified as follows: no treatment group, drug therapy group, and chemoradiotherapy group. Local control rate and median survival time were 0{\%} and 4 months in the no treatment group, 0{\%} and 10 months in the drug therapy group, and 83{\%} and 20 months in the chemoradiotherapy group. Chemoradiotherapy was useful for long-term control of a locoregional site and for maintenance of QOL. In addition, chemoradiotherapy may be a useful treatment option for M1 disease patients for improving prognosis.",
author = "Mioko Matsuo and Toshimitsu Nishijima and Koji Koike",
year = "2017",
month = "1",
day = "1",
doi = "10.5981/jjhnc.43.488",
language = "English",
volume = "43",
pages = "488--492",
journal = "Japanese Journal of Head and Neck Cancer",
issn = "1349-5747",
publisher = "Nihon Tokeibu Gan Gakkai",
number = "4",

}

TY - JOUR

T1 - Utility of chemoradiotherapy for head and neck cancer with distant metastases at initial presentation

AU - Matsuo, Mioko

AU - Nishijima, Toshimitsu

AU - Koike, Koji

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Metastatic (M1) disease is the state in which a malignant tumor has generalized and the principal treatment is drug therapy. However, for head and neck cancer with distant metastases at initial presentation, local control is important for maintaining Quality of Life (QOL) . We retrospectively reviewed 11 cases of head and neck cancer with distant metastases at initial presentation at our hospital from January 2014 to June 2016. Initial treatments were classified as follows: no treatment group, drug therapy group, and chemoradiotherapy group. Local control rate and median survival time were 0% and 4 months in the no treatment group, 0% and 10 months in the drug therapy group, and 83% and 20 months in the chemoradiotherapy group. Chemoradiotherapy was useful for long-term control of a locoregional site and for maintenance of QOL. In addition, chemoradiotherapy may be a useful treatment option for M1 disease patients for improving prognosis.

AB - Metastatic (M1) disease is the state in which a malignant tumor has generalized and the principal treatment is drug therapy. However, for head and neck cancer with distant metastases at initial presentation, local control is important for maintaining Quality of Life (QOL) . We retrospectively reviewed 11 cases of head and neck cancer with distant metastases at initial presentation at our hospital from January 2014 to June 2016. Initial treatments were classified as follows: no treatment group, drug therapy group, and chemoradiotherapy group. Local control rate and median survival time were 0% and 4 months in the no treatment group, 0% and 10 months in the drug therapy group, and 83% and 20 months in the chemoradiotherapy group. Chemoradiotherapy was useful for long-term control of a locoregional site and for maintenance of QOL. In addition, chemoradiotherapy may be a useful treatment option for M1 disease patients for improving prognosis.

UR - http://www.scopus.com/inward/record.url?scp=85040963297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040963297&partnerID=8YFLogxK

U2 - 10.5981/jjhnc.43.488

DO - 10.5981/jjhnc.43.488

M3 - Article

AN - SCOPUS:85040963297

VL - 43

SP - 488

EP - 492

JO - Japanese Journal of Head and Neck Cancer

JF - Japanese Journal of Head and Neck Cancer

SN - 1349-5747

IS - 4

ER -